THALASSEMIA, BETA
Clinical trials for THALASSEMIA, BETA explained in plain language.
Never miss a new study
Get alerted when new THALASSEMIA, BETA trials appear
Sign up with your email to follow new studies for THALASSEMIA, BETA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy aims to free patients from lifelong blood transfusions
⭐️ CURE ⭐️ Recruiting nowThis study follows people who have already received an experimental gene therapy called BRL-101 for transfusion-dependent β-thalassemia, a severe blood disorder requiring regular transfusions. Researchers will monitor participants over the long term to check for safety issues, su…
Matched conditions: THALASSEMIA, BETA
Sponsor: Bioray Laboratories • Aim: ⭐️ CURE ⭐️
Last updated Jul 23, 2026 00:00 UTC
-
New transplant approach could help more patients with blood disorders
Disease control Recruiting nowThis study is testing a stem cell transplant from half-matched (haploidentical) donors for people with sickle cell disease or beta-thalassemia. Before the transplant, patients receive drugs to lower their immune system, which may reduce the risk of serious side effects like graft…
Matched conditions: THALASSEMIA, BETA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC